Range of assays

iCS-digital™ PSC: digital PCR-based assay enabling the identification of genomic abnormalities in hPSCs (human Pluripotent Stem Cells).

Duo iCS-Karyo: combine an exhaustive G-banding analysis with the high performance of iCS-digital™ PSC to identify the most recurrent abnormalities in hPSCs.

G-Banding karyotyping: the traditional and best-known technique for controlling genomic stability in human stem cells.

Stem-Seq™ range: a range of NGS-based assay enabling CNV and SNV detection in any human cell type.

iCS-digital™ Aneuploidy: digital PCR-based assay enabling the identification of genomic abnormalities in any human cell type.

iCS-digital™ MSC: digital PCR-based assay enabling a faster and more cost-effective genomic stability test for human Mesenchymal Stromal Cells (hMSCs).

Not sure which assay
is right for you ?

Try and look for the test you need based on the cell type you work with, or contact us directly for advice.

Important announcement for our US clients: we are moving!

As of July 17, our new address will be:

400 Park Offices Drive, Room 104

Research Triangle Park, Durham, North Carolina 27709

Please note that we will be closed from July 12 to 16

during the transition.

Download this file immediately

Please enter your details below

Access the webinar immediately

Please enter your details below

Upcoming webinar

Join us LIVE for a Q&A session on the latest iCS-digital™ PSC upgrade.

Find out what it means for you and ask all your questions

Juline VINCENT our R&D Project Manager and Digital PCR expert will answer you LIVE.

SAVE THE DATE: Thursday, November 7, 6pm CET/9am PDT/12 pm EDT.

Upcoming webinar

Join us LIVE for our webinar “Genomic stability made easy” to discover how Stem Genomics has turned cutting-edge technologies into easy testing solutions accessible to most labs.

Get expert opinions and user perspectives on our genomic stability assays in the context of iPSC research.

Happening on Tuesday, November 14, 6 pm CET

Download this file immediately

Please enter your e-mail address.